Top Industry Leaders in the MEA Anti Fungal Agents Market
Latest MEA Anti-Fungal Agents Companies Update
Pfizer collaborates with the Egyptian Ministry of Health to launch a program for early diagnosis and treatment of fungal infections in high-risk groups.
Roche enters into a partnership with a Moroccan pharmaceutical company to distribute its antifungal drug, Posaconazole, in the region.
Glenmark Pharmaceuticals launches Itraconazole capsules in Kenya, expanding access to a first-line antifungal medication for patients with blastomycosis.
Janssen Pharmaceuticals launches Isavuconazole in South Africa, offering a broad-spectrum antifungal agent for the treatment of various fungal infections
List of MEA Anti-Fungal Agents Key Companies in the Market
- Novartis AG
- Pfizer Inc.
- Sanofi-Aventis
- Merck & Co. Inc.
- Enzon Pharmaceuticals Inc.
- Bayer AG
- Astellas Pharma Inc.
- GlaxoSmithKline plc
- Abbott
- Sigma-Aldrich